Literature DB >> 23670045

A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation.

Didem Torun1, Gülhis Deda, Mehmet Ertem, Zümrüt Uysal, Erkan Yılmaz, Nejat Akar.   

Abstract

Protein C inhibitor is a heparin dependent serine protease inhibitor found in human plasma, urine and other body fluids. It was originally identified as an inhibitor of activated protein C. Stroke is an important cause of morbidity and mortality in the pediatric age group. In this study we analyzed the protein C inhibitor gene mutations in Turkish pediatric stroke patients. We found a missense mutation of G to A at nucleotide 6760 in exon 2, resulting in a transition serine to asparagine (p.Ser188Asp) and in a child and his father and also we found same alteration in exon 2 in an another pediatric stroke case following bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670045     DOI: 10.1007/s11033-013-2644-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

1.  Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct.

Authors:  N Akar; E Akar; G Deda; T Sipahi; A Orsal
Journal:  J Child Neurol       Date:  1999-11       Impact factor: 1.987

2.  Factor V 1691 G-A mutation distribution in a healthy Turkish population.

Authors:  Namık Özbek
Journal:  Turk J Haematol       Date:  2009-03-05       Impact factor: 1.831

Review 3.  Inflammation and the activated protein C anticoagulant pathway.

Authors:  Charles T Esmon
Journal:  Semin Thromb Hemost       Date:  2006-04       Impact factor: 4.180

4.  Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct.

Authors:  N Akar; E Yilmaz; E Akar; G Deda; T Sipahi
Journal:  Haemostasis       Date:  2000 May-Jun

5.  Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway.

Authors:  Z Laszik; A Mitro; F B Taylor; G Ferrell; C T Esmon
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

Review 6.  The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis.

Authors:  K Suzuki
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  Absence of mutations in the PCI gene in subfertile men.

Authors:  Judith Gianotten; Alinda W M Schimmel; Fulco van der Veen; M Paola Lombardi; Joost C M Meijers
Journal:  Mol Hum Reprod       Date:  2004-09-17       Impact factor: 4.025

9.  Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.

Authors:  T W Stief; K P Radtke; N Heimburger
Journal:  Biol Chem Hoppe Seyler       Date:  1987-10

Review 10.  Activated protein C.

Authors:  J H Griffin; J A Fernández; A J Gale; L O Mosnier
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.